Research Advisory Committee on Gulf War Veterans' Illnesses; Notice of Meeting, 51400 [2014-20484]
Download as PDF
<![CDATA[
pmangrum on DSK3VPTVN1PROD with NOTICES
51400
Federal Register / Vol. 79, No. 167 / Thursday, August 28, 2014 / Notices
(Other than Temporomandibular Joint
Conditions) Disability Benefits
Questionnaire, VA Form 21–0960–D–1.
g. Endocrine Diseases (other than
Thyroid, Parathyroid or Diabetes
Mellitus) Disability Benefits
Questionnaire, VA Form 21–0960–E–2.
h. Thyroid & Parathyroid Conditions
Disability Benefits Questionnaire, VA
Form 21–0960–E–3.
l. Hernias (Including Abdominal,
Inguinal, and Femoral Hernias)
Disability Benefits Questionnaire, VA
Form 21–0960–H–1.
m. HIV-Related Illnesses Disability
Benefits Questionnaire, VA Form 21–
0960–I–2.
n. Infectious Diseases (other than HIVRelated Illness, Chronic Fatigue
Syndrome, and Tuberculosis) Disability
Benefits Questionnaire, VA Form 21–
0960I–3.
o. Systemic Lupus Erythematosus
(SLE) and Other Autoimmune Diseases
Disability Benefits Questionnaire, VA
Form 21–0960–I–4.
p. Nutritional Deficiencies Disability
Benefits Questionnaire, VA Form 21–
0960–I–5.
q. Urinary Tract (including Bladder &
Urethra) Conditions (excluding Male
Reproductive System) Disability
Benefits Questionnaire, VA Form 21–
0960–J–4.
r. Respiratory Conditions (other than
Tuberculosis and Sleep Apnea)
Disability Benefits Questionnaire, VA
Form 21–0960–L–1.
s. Loss of Sense of Smell and/or Taste
Disability Benefits Questionnaire, VA
Form 21–0960–N–3.
t. Sinusitis/Rhinitis and Other
Conditions of the Nose, Throat, Larynx,
and Pharynx Disability Benefits
Questionnaire, VA Form 21–0960–N–4.
u. Chronic Fatigue Syndrome
Disability Benefits Questionnaire, VA
Form 21–0960–Q–1.
OMB Control Number: 2900–0781.
Type of Review: Revised collection.
Abstract: Data collected on VA Form
21–0960 series will be used obtain
information from claimants treating
physician that is necessary to adjudicate
a claim for disability benefits.
Affected Public: Individuals or
households.
Estimated Annual Burden: 53,750
hours.
(a) VAF 21–0960–C–3—5,000
(b) VAF 21–0960–C–6—1,250
(c) VAF 21–0960–C–7—1,250
(d) VAF 21–0960–C–11—1,250
(e) VAF 21–0960–D–1—1,250
(f) VAF 21–0960–E–2—2,500
(g) VAF 21–0960–E–3—2,500
(h) VAF 21–0960–H–1—3,750
(i) VAF 21–0960–I–2—1,250
VerDate Mar<15>2010
14:14 Aug 27, 2014
Jkt 232001
(j) VAF 21–0960–I–3—2,500
(k) VAF 21–0960–I–4—2,500
(l) VAF 21–0960–I–5—1,250
(m) VAF 21–0960–J–4—3,750
(n) VAF 21–0960–L–1—10,000
(o) VAF 21–0960–N–3—1,250
(p) VAF 21–0960–N–4—10,000
(q) VAF 21–0960–Q–1—2,500
Estimated Average Burden per
Respondent:
(a) VAF 21–0960–C–3—30 minutes
(b) VAF 21–0960–C–6—15 minutes
(c) VAF 21–0960–C–7—15 minutes
(d) VAF 21–0960–C–11—15 minutes
(e) VAF 21–0960–D–1—15 minutes
(f) VAF 21–0960–E–2—15 minutes
(g) VAF 21–0960–E–3—15 minutes
(h) VAF 21–0960–H–1—15 minutes
(i) VAF 21–0960–I–2—15 minutes
(j) VAF 21–0960–I–3—15 minutes
(k) VAF 21–0960–I–4—30 minutes
(l) VAF 21–0960–I–5—15 minutes
(m) VAF 21–0960–J–4—15 minutes
(n) VAF 21–0960–L–1—30 minutes
(o) VAF 21–0960–N–3—15 minutes
(p) VAF 21–0960–N–4—30 minutes
(q) VAF 21–0960–Q–1—15 minutes
Frequency of Response: On occasion.
Estimated Number of Respondents:
TOTAL: 160,000.
(a) VAF 21–0960–C–3—10,000
(b) VAF 21–0960–C–6—5,000
(c) VAF 21–0960–C–7—5,000
(d) VAF 21–0960–C–11—5,000
(e) VAF 21–0960–D–1—5,000
(f) VAF 21–0960–E–2—10,000
(g) VAF 21–0960–E–3—10,000
(h) VAF 21–0960–H–1—15,000
(i) VAF 21–0960–I–2—5,000
(j) VAF 21–0960–I–3—10,000
(k) VAF 21–0960–I–4—5,000
(l) VAF 21–0960–I–5—5,000
(m) VAF 21–0960–J–4—15,000
(n) VAF 21–0960–L–1—20,000
(o) VAF 21–0960–N–3—5,000
(p) VAF 21–0960–N–4—20,000
(q) VAF 21–0960–Q–1—10,000
Dated: August 25, 2014.
By direction of the Secretary.
Crystal Rennie,
VA Clearance Officer, Department of Veterans
Affairs.
[FR Doc. 2014–20472 Filed 8–27–14; 8:45 am]
BILLING CODE 8320–01–P
DEPARTMENT OF VETERANS
AFFAIRS
Research Advisory Committee on Gulf
War Veterans’ Illnesses; Notice of
Meeting
The Department of Veterans Affairs
(VA) gives notice under the Federal
Advisory Committee Act, 5 U.S.C.
App.2 that the Research Advisory
Committee on Gulf War Veterans’
PO 00000
Frm 00106
Fmt 4703
Sfmt 9990
Illnesses will meet on September 22 and
23, 2014, in the greater Washington, DC,
area. On Monday, September 22, the
meeting will be held in 810 Vermont
Avenue NW., Room 230, Washington,
DC, from 9:00 a.m. until 5:15 p.m. On
Tuesday, September 23, the meeting
will be held at the VHA National
Conference Center, 2011 Crystal Drive,
Suite 150, Arlington, Virginia from 9:00
a.m. until 1:00 p.m. All sessions will be
open to the public, although space will
be limited on September 23. For
interested parties who cannot attend in
person, there will be a toll-free
telephone number.
The purpose of the Committee is to
provide advice and make
recommendations to the Secretary of
Veterans Affairs on proposed research
studies, research plans, and research
strategies relating to the health
consequences of military service in the
Southwest Asia theater of operations
during the Gulf War.
The Committee will review VA
program activities related to Gulf War
Veterans’ illnesses, and updates on
relevant scientific research published
since the last Committee meeting.
Presentations on September 22 will
include updates on the VA Gulf War
Research Program, followed by research
presentations on a treatment for pain,
neuroimaging in Gulf War Veterans, and
drug trials in animal models. The
Committee will devote September 23 to
a discussion of Committee activities.
The meeting will include time
reserved for public comments on both
days in the afternoon. A sign-up sheet
for 5-minute comments will be available
at the meeting. Individuals who wish to
address the Committee may submit a 1–
2 page summary of their comments for
inclusion in the official meeting record.
Members of the public may also submit
written statements for the Committee’s
review to Dr. Roberta White at rwhite@
bu.edu.
Because the meeting is being held in
a government building, a photo I.D.
must be presented as part of the
clearance process. Therefore, any person
attending should allow an additional 15
minutes to complete this process before
the meeting begins. Any member of the
public seeking additional information
should contact Dr. White, Scientific
Director, at (617) 638–4620 or Dr. Victor
Kalasinsky, Designated Federal Officer,
at (202) 443–5682.
Dated: August 25, 2014.
Rebecca Schiller,
Committee Management Officer.
[FR Doc. 2014–20484 Filed 8–27–14; 8:45 am]
BILLING CODE P
E:\FR\FM\28AUN1.SGM
28AUN1
]]>Agencies
[Federal Register Volume 79, Number 167 (Thursday, August 28, 2014)]
[Notices]
[Page 51400]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-20484]
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Research Advisory Committee on Gulf War Veterans' Illnesses;
Notice of Meeting
The Department of Veterans Affairs (VA) gives notice under the
Federal Advisory Committee Act, 5 U.S.C. App.2 that the Research
Advisory Committee on Gulf War Veterans' Illnesses will meet on
September 22 and 23, 2014, in the greater Washington, DC, area. On
Monday, September 22, the meeting will be held in 810 Vermont Avenue
NW., Room 230, Washington, DC, from 9:00 a.m. until 5:15 p.m. On
Tuesday, September 23, the meeting will be held at the VHA National
Conference Center, 2011 Crystal Drive, Suite 150, Arlington, Virginia
from 9:00 a.m. until 1:00 p.m. All sessions will be open to the public,
although space will be limited on September 23. For interested parties
who cannot attend in person, there will be a toll-free telephone
number.
The purpose of the Committee is to provide advice and make
recommendations to the Secretary of Veterans Affairs on proposed
research studies, research plans, and research strategies relating to
the health consequences of military service in the Southwest Asia
theater of operations during the Gulf War.
The Committee will review VA program activities related to Gulf War
Veterans' illnesses, and updates on relevant scientific research
published since the last Committee meeting. Presentations on September
22 will include updates on the VA Gulf War Research Program, followed
by research presentations on a treatment for pain, neuroimaging in Gulf
War Veterans, and drug trials in animal models. The Committee will
devote September 23 to a discussion of Committee activities.
The meeting will include time reserved for public comments on both
days in the afternoon. A sign-up sheet for 5-minute comments will be
available at the meeting. Individuals who wish to address the Committee
may submit a 1-2 page summary of their comments for inclusion in the
official meeting record. Members of the public may also submit written
statements for the Committee's review to Dr. Roberta White at
rwhite@bu.edu.
Because the meeting is being held in a government building, a photo
I.D. must be presented as part of the clearance process. Therefore, any
person attending should allow an additional 15 minutes to complete this
process before the meeting begins. Any member of the public seeking
additional information should contact Dr. White, Scientific Director,
at (617) 638-4620 or Dr. Victor Kalasinsky, Designated Federal Officer,
at (202) 443-5682.
Dated: August 25, 2014.
Rebecca Schiller,
Committee Management Officer.
[FR Doc. 2014-20484 Filed 8-27-14; 8:45 am]
BILLING CODE P
